Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress

Go back to Atara Biotherapeutics Announces Second Quarter 2023 Financial Results and Operational Progress
(NASDAQ: ATRA) Delayed: 10.46 --0 (-0%)
Previous Close $10.46    52 Week High $40.80 
Open $10.46    52 Week Low $12.45 
Day High $10.46    P/E N/A 
Day Low $10.46    EPS $0.00 
Volume 221